Indo Us Biotech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has submitted its financial results for the period ending March 31, 2025 to the NSE. The filing relates to the company's fourth quarter and full-year results for FY25. No specific financial figures, growth rates, or auditor remarks were provided in this announcement notice itself. Investors would need to refer to the actual results document for detailed numbers and management commentary.
This is a routine regulatory filing and does not by itself indicate any positive or negative development for shareholders. The actual financial performance and any notable items should be reviewed from the detailed results document.